Lifitegrast + Perfluorohexyloctane for Dry Eye Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
Are You a Good Fit for This Trial?
Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Lifitegrast
- Perfluorohexyloctane
How Is the Trial Designed?
6
Treatment groups
Experimental Treatment
Active Control
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Bausch & Lomb Incorporated
Lead Sponsor
Dr. Christina Ackermann
Bausch & Lomb Incorporated
Chief Medical Officer since 2023
MD from Harvard Medical School
Brent Saunders
Bausch & Lomb Incorporated
Chief Executive Officer since 2023
BA from the University of Pittsburgh, JD and MBA from Temple University
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.